血小板衍生的循环溶性P-选择素足以诱导造血干细胞动员
Tso-Fu Wang1,2,3, Yu-Shan Liou4, Shang-Hsien Yang2,3,5
1Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.
Stem cell research & therapy
|October 20, 2023
概括
血小板释放的可溶性P-selectin (sP-sel) 通过破坏它们与骨髓 stromal 细胞的相互作用来调动造血干细胞 (HSC). 这一发现为HSC动员提供了一种新的策略,有可能改善移植结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 颗粒细胞殖民地刺激因子 (G-CSF) 调动造血干细胞 (HSCs) 进行移植.
- G-CSF的动员对于成功的高细胞移植至关重要,但有些捐赠者是不好的动员者.
- 通过G-CSF调解的高血压动员的确切机制尚不清楚,需要进一步研究.
研究的目的:
- 研究P-选择因和P-选择因糖蛋白连接体-1 (PSGL-1) 在HSC调动中的作用.
- 确定阻断PSGL-1和P-选择因子相互作用是否可以增强HSC动员.
- 探索可溶性P-选择素 (sP-sel) 作为一种潜在的HSC调动剂.
主要方法:
- 在G-CSF给药后,测量了人类和小鼠的血sP细胞水平.
- 利用缺乏P-选择因的小鼠来评估G-CSF诱导的高细胞动员.
- 研究了重组sP-sel对小鼠HSC调动的影响.
主要成果:
- 使用G-CSF显著增加了血sP细胞水平.
- 在小鼠中,P-选择因缺乏损害了G-CSF诱导的HSC调动.
- 血小板衍生的sP-sel足以通过破坏HSC-细胞相互作用来调动HSC.
结论:
- P-选择素是G-CSF介导的HSC动员的一个关键因素.
- 可溶性P-选择素作为动员高细胞的内源性剂.
- 与G-CSF相比,sP-sel提供了一个潜在的更快,更方便的HSC动员方法.
更多相关视频
10:56A Novel Three-dimensional Flow Chamber Device to Study Chemokine-directed Extravasation of Cells Circulating under Physiological Flow Conditions
Published on: July 15, 2013
18.5K
11:04Systematic Analysis of In Vitro Cell Rolling Using a Multi-well Plate Microfluidic System
Published on: October 16, 2013
12.1K
相关概念视频
01:25Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:21Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K